Literature DB >> 20728008

A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder.

Seetal Dodd1, Alan J M Brnabic, Lesley Berk, Paul B Fitzgerald, Anthony R de Castella, Sacha Filia, Kate Filia, Katarina Kelin, Meg Smith, William Montgomery, Jayashri Kulkarni, Michael Berk.   

Abstract

BACKGROUND: Tobacco smoking is more prevalent among people with mental illnesses, including bipolar disorder, than in the general community. Most data are cross-sectional, and there are no prospective trials examining the relationship of smoking to outcome in bipolar disorder. The impact of tobacco smoking on mental health outcomes was investigated in a 24-month, naturalistic, longitudinal study of 240 people with bipolar disorder or schizoaffective disorder.
METHOD: Participants were interviewed and data recorded by trained study clinicians at 9 interviews during the study period.
RESULTS: Comparisons were made between participants who smoked daily (n = 122) and the remaining study participants (n = 117). During the 24-month study period, the daily smokers had poorer scores on the Clinical Global Impressions-Depression (P = .034) and Clinical Global Impressions-Overall Bipolar (P = .026) scales and had lengthier stays in hospital (P = .012), compared with nonsmokers. LIMITATIONS: Smoking status was determined by self-report. Nicotine dependence was not measured.
CONCLUSION: These findings suggest that smoking is associated with poorer mental health outcomes in bipolar and schizoaffective disorder. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20728008     DOI: 10.1016/j.comppsych.2009.12.001

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  18 in total

Review 1.  Genetics of smoking and depression.

Authors:  Ming T Tsuang; Tracee Francis; Kyle Minor; Alison Thomas; William S Stone
Journal:  Hum Genet       Date:  2012-04-17       Impact factor: 4.132

2.  Seasonality, smoking and history of poor treatment compliance are strong predictors of dropout in a naturalistic 6 year follow-up of bipolar patients.

Authors:  Elena Ezquiaga; Aurelio García-López; Consuelo de Dios; Jose Luis Agud; David Albillo; Lorena Vega-Piris
Journal:  Psychiatr Q       Date:  2014-12

3.  Nicotine intake and smoking topography in smokers with bipolar disorder.

Authors:  Jill M Williams; Kunal K Gandhi; Shou-En Lu; Marc L Steinberg; Neal L Benowitz
Journal:  Bipolar Disord       Date:  2012-09       Impact factor: 6.744

4.  A Review of Smoking Cessation in Bipolar Disorder: Implications for Future Research.

Authors:  Tony P George; Becky S Wu; Andrea H Weinberger
Journal:  J Dual Diagn       Date:  2012-05-11

5.  Sequential behavioral treatment of smoking and weight control in bipolar disorder.

Authors:  Sacha L Filia; Amanda L Baker; Jayashri Kulkarni; Jill M Williams
Journal:  Transl Behav Med       Date:  2012-09       Impact factor: 3.046

6.  Cigarette smoking and its relationship to mood disorder symptoms and co-occurring alcohol and cannabis use disorders following first hospitalization for bipolar disorder.

Authors:  Jaimee L Heffner; Melissa P DelBello; Robert M Anthenelli; David E Fleck; Caleb M Adler; Stephen M Strakowski
Journal:  Bipolar Disord       Date:  2012-02       Impact factor: 6.744

Review 7.  Tobacco use treatment in primary care patients with psychiatric illness.

Authors:  Joseph M Cerimele; Abigail C Halperin; Andrew J Saxon
Journal:  J Am Board Fam Med       Date:  2014 May-Jun       Impact factor: 2.657

Review 8.  Associations between health risk behaviors and symptoms of schizophrenia and bipolar disorder: a systematic review.

Authors:  Joseph M Cerimele; Wayne J Katon
Journal:  Gen Hosp Psychiatry       Date:  2012-10-06       Impact factor: 3.238

9.  Use of cotinine urinalysis to verify self-reported tobacco use among male psychiatric out-patients.

Authors:  Yatan Pal Singh Balhara; Raka Jain; A Shyam Sundar; Rajesh Sagar
Journal:  Lung India       Date:  2012-07

10.  Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption.

Authors:  Valentina Echeverria Moran
Journal:  Front Pharmacol       Date:  2012-10-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.